NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

No flipper, what that Helen Bulbeck quote that Lykiri shared means is that the payment schedule for DCVax is “staged” in several payments over time, not all at once. According to Advent’s current pricelist to manufacture DCVax for “specials” patients in the UK, Advent charges £50k up front for tumor tissue processing, then £100k to manufacture 6 doses for the first year, then £25k for each semi-annual dose for the next two years, which adds up to that £250k.

I think with automated manufacturing, the final commercial negotiated price will be under £200k, and along with this “staged” payment schedule, it will make it more feasible for insurance reimbursement.

From Helen Bulbeck to Everyone 08:38 PM ?DCVax is around £250k but is staged. NWB is seeking to bring the cost down so that market access can be achieved.